In vitro assessment of bone marrow endothelial colonies (CFU-En) in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 32, Issue 12, 2003, Pages 1165-1173

  Lanza, F ^a   Campioni, D ^a   Punturieri, M ^a   Moretti, S ^a   Dabusti, M ^b   Spanedda, R ^a   Castoldi, G ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b International Cancer Centre   (Italy)

Author keywords

Angiogenesis; Autologous transplantation; Bone marrow endothelial cells; Non Hodgkin's lymphoma

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CANCER REGRESSION; CANCER STAGING; CELL COUNT; CELL CULTURE; CELL GROWTH; COLONY FORMING CELL; COLONY FORMING UNIT; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL LINEAGE; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; COMBINED MODALITY THERAPY; ENDOTHELIAL CELLS; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, HIGH-GRADE; LYMPHOMA, LOW-GRADE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0346656759     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704279     Document Type: Article

References (40)

1. Prockop DJ. Marrow stromal cells as stem cells for non hematopoietic tissues. Science 1997; 276: 71-74.
2. Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cell. J Cell Physiol 1998; 176: 57-66.
3. Rafii S, Shapiro F, Rimarachin J et al. Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood 1994; 84: 10-19.
4. Rafii S, Mohle R, Shapiro F et al. Regulation of hematopoiesis by microvascular endothelium. Leuk Lymphoma 1997; 27: 375-378.
5. Rood PML, Gerritsen WR, Kramer D et al. Adhesion of hematopoietic progenitor cells to human bone marrow or umbilical vein derived endothelial cell lines: a comparison. Exp Hematol 1999; 27: 1306-1314.
6. Salvucci O, Lei Y, Villalba S et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002; 99: 2703-2711.
7. Shi Q, Rafii S, Hong-De W M et al. Evidence for circulating bone marrow derived endothelial cells. Blood 1998; 92: 362-367.
8. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
9. Aguayo A, Kantarjian H, Manshouri et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240-2245.
10. Hamada K, Oike Y, Takakura N et al. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculogenesis and hematopoiesis. Blood 2000; 96: 3793-3800.
11. Vacca A, Ribatti D, Roncali L et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503-508.
12. Ribatti D, Vacca A, Nico B et al. Angiogenesis spectrum in the stroma of B-cell non Hodgkin's lymphomas. An immunohistochemical and structural study. Eur J Haematol 1996; 56: 45-53.
13. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309-313.
14. Perez-Atayde A, Sallan S, Tedrow U et al. Spectrum of tumor angiogenesis in bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815-821.
15. Deeg HJ. Marrow stroma in MDS: culprit or bystander? Leuk Res 2002; 26: 687-688.
16. Dominici M, Campioni D, Lanza F et al. Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinical-biological features. Leukemia 2001; 15: 171-176.
17. Vega F, Medeiros Lj, Lang Wen-Hua et al. The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumors. Br J Hematol 2002; 117: 569-576.
18. Castro-Malaspina H, Gay RE, Resnick G et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980; 56: 289-301.
19. Lanza F, Healy L, Sutherland DR. Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 2001; 15: 1-13.
20. Campioni D, Punturieri M, Bardi A et al. In vitro evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach. Leak Res 2003, (in press).
21. Dias S, Choy M, Alitalo K, Rafii S. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 2002; 99: 2179-2184.
22. Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 1997; 90: 3167-3172.
23. Bertolini F, Paolucci M, Peccatori F et al. Angiogenic growth factors and endostatin in non Hodgkin's lymphoma. Br J Haematol 1999; 106: 504-509.
24. Dominici M, Hofmann TJ, Horwitz EM. Bone marrow mesenchymal cells: biological properties and clinical application. J Biol Regal Homeost Agents 2001; 15: 28-37.
25. Soligo DA, Lambertenghi Deliliers G, Servida F et al. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients. Bone Marrow Transpl 1998; 21: 15-22.
26. Lanza F, Campioni D, Moretti S et al. CD34+ cell subsets and long-term culture colony forming cells (LTC-CFC) evaluated on both autologous and normal bone marrow stroma predict long term hematopoietic engraftment in patients receiving autologous peripheral blood stem cell transplantation. Exp Hematol 2001; 29: 1484-1493.
27. Del Canizo C, Lopez N, Caballero D et al. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation. Bone Marrow Transpl 1999; 23: 901-905.
28. D'Arcangelo D, Facchiano F, Barlucchi M et al. Acidosis inhibit endothelial cells apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. Circ Res 2000; 86: 312-318.
29. Bautz F, Rafii S, Kanz L, Mohle R. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. Exp Hematol 2000; 28: 700-706.
30. Lenton K. VEGFR-2 (KDR/Flk-1). J Biol Regul Homeost Agents 2002; 16: 227-232.
31. Wang JM, Kumar S, van Agthoven A et al. Irradiation induces up-regulation of E-9 protein (CD105) in human vascular endothelial cells. Int J Cancer 1995; 62: 791-796.
32. Huang WQ, Wang QR. Bone marrow endothelial cells secrete thymosin β4 and AcSDKP. Exp Hematol 2001; 29: 12-18.
33. Guest I, Utrecht J. Bone marrow stem cell protection from chemotherapy by low-molecular-weight compounds. Exp Hematol 2001; 29: 123-137.
34. Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.
35. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-78.
36. Murayama T, Tepper OM, Silver M et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neo vascularization in vivo. Exp Hematol 2002; 30: 967-972.
37. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
38. Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularisation. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
39. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal vascularization. J Clin Invest 1999; 103: 1231-1234.
40. Crosby JR, Kaminski WE, Shatteman G et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000; 87: 728-730.